Clinical Assessment of Lesions by Primary Care Clinicians (PCC) Investigators
| Clinical Diagnosis | n = 177 |
|---|---|
| Benign | 155/177 (87.6%) |
| Malignant | 22/177 (12.4%) |
| Level of Confidence | |
| High | 160/177 (90.4%) |
| Low | 17/177 (9.6%) |
| Malignant Diagnoses | |
| BCC (Basal Cell Carcinoma) | 9/22 (40.9%) |
| SCC (Squamous Cell Carcinoma) | 8/22 (36.4%) |
| Melanoma | 5/22 (22.7%) |
| Benign Diagnoses | |
| Seborrheic Keratosis | 51/155 (32.9%) |
| Solar Lentigo | 31/155 (20.0%) |
| Actinic Keratosis | 17/155 (11.0%) |
| Mildly atypical melanocytic nevus | 12/155 (7.7%) |
| Benign other | 10/155 (6.5%) |
| Simple Lentigo | 7/155 (4.5%) |
| Dermatofibroma | 7/155 (4.5%) |
| Angioma or vascular lesion | 6/155 (3.9%) |
| Senile Purpure | 2/155 (1.3%) |
| Sebaceous hyperplasia | 2/155 (1.3%) |
| Moderately atypical melanocytic nevus | 2/155 (1.3%) |
| Epidermal cyst | 2/155 (1.3%) |
| Benign melanocytic nevus | 2/155 (1.3%) |
| Verruca | 1/155 (0.6%) |
| Spitz Nevus | 1/155 (0.6%) |
| Blue nevus | 1/155 (0.6%) |
| Acrochordon | 1/155 (0.6%) |
| Decision Regarding Further Evaluation | |
| Not concerned | 150/177 (84.7%) |
| Biopsy | 26/177 (14.7%) |
| Refer to Dermatologist | 1/177 (0.6%) |